Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gilaranco is a leading Iranian pharmaceutical company focused on the production of high-quality generic and specialized medicinal products. Established in 1986, the company has built a strong reputation for its expertise in topical formulations, including creams, ointments, and gels, as well as oral liquids and suspensions. Its manufacturing facilities, located in the Rasht Industrial City, operate under strict Good Manufacturing Practice (GMP) guidelines to serve both domestic and international markets. Gilaranco's product portfolio spans multiple therapeutic areas such as dermatology, pediatrics, and respiratory health, featuring well-known treatments for scabies and inflammatory skin conditions. In addition to its own product line, the company offers contract manufacturing services, leveraging its advanced production capabilities to support the broader healthcare industry. The company remains a key player in the Iranian pharmaceutical landscape, dedicated to improving patient access to essential medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gilaranco.